About this Journal Submit a Manuscript Table of Contents
Autoimmune Diseases
Volume 2010 (2010), Article ID 731834, 5 pages
http://dx.doi.org/10.4061/2010/731834
Research Article

Addison's Disease Revisited in Poland: Year 2008 versus Year 1990

1Department of Endocrinology, Centre for Postgraduate Medical Education, Bielanski Hospital, Ceglowska 80, 01-809 Warsaw, Poland
2Department of Biochemistry and Molecular Biology, Centre for Postgraduate Medical Education, Bielanski Hospital, Ceglowska 80, 01-809 Warsaw, Poland

Received 28 August 2009; Accepted 30 March 2010

Academic Editor: Corrado Betterle

Copyright © 2010 Anna A. Kasperlik-Zaluska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. Guttman, “Addison's disease,” Archives of Pathology, vol. 10, pp. 742–752, 1930.
  2. C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta, “Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction,” Endocrine Reviews, vol. 23, no. 3, pp. 327–364, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. A. A. Kasperlik-Załuska, B. Czarnocka, W. Czech, et al., “Secondary adrenal insufficiency associated with autoimmune disorders: a report of twenty-five cases,” Clinical Endocrinology, vol. 49, no. 6, pp. 779–783, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Kasperlik-Załuska, B. Czarnocka, and W. Czech, “Autoimmunity as the most frequent cause of idiopathic secondary adrenal insufficiency: report of 111 cases,” Autoimmunity, vol. 36, no. 3, pp. 155–159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Kasperlik-Załuska, B. Migdalska, B. Czarnocka, J. Drac-Kaniewska, E. Niegowska, and W. Czech, “Association of Addison's disease with autoimmune disorders—a long-term observation of 180 patients,” Postgraduate Medical Journal, vol. 67, no. 793, pp. 984–987, 1991. View at Scopus
  6. W. Arlt and B. Allolio, “Adrenal insufficiency,” The Lancet, vol. 361, no. 9372, pp. 1881–1893, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Kasperlik-Załuska, B. Czarnocka, and W. Czech, “High prevalence of thyroid autoimmunity in idiopathic Addison's disease,” Autoimmunity, vol. 18, no. 3, pp. 213–216, 1994. View at Scopus
  8. W. Jeske, K. Gajl-Pęczalska, and A. Kasperlik-Załuska, “Antibodies directed against adrenal glands in Addison's and Cushing's diseases,” Polskie Archiwum Medycyny Wewnetrznej, vol. 47, no. 5, pp. 485–491, 1971. View at Scopus
  9. O. Ekwall, H. Hedstrand, L. Grimelius, et al., “Identification of tryptophan hydroxylase as an intestinal autoantigen,” The Lancet, vol. 352, no. 9124, pp. 279–283, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Erichsen, K. Lovas, B. Skinningsrud, et al., “Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 12, pp. 4882–4890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Soule, “Addison's disease in Africa—a teaching hospital experience,” Clinical Endocrinology, vol. 50, no. 1, pp. 115–120, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Kong and W. Jeffcoate, “Eighty-six cases of Addison's disease,” Clinical Endocrinology, vol. 41, no. 6, pp. 757–761, 1994. View at Scopus
  13. P. M. J. Zelissen, E. J. E. G. Bast, and R. J. M. Croughs, “Associated autoimmunity in Addison's disease,” Journal of Autoimmunity, vol. 8, no. 1, pp. 121–130, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Falorni, S. Laureti, A. de Bellis, et al., “Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 4, pp. 1598–1604, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. O. Winqvist, F. A. Karlsson, and O. Kämpe, “21-hydroxylase, a major autoantigen in idiopathic Addison's disease,” The Lancet, vol. 339, no. 8809, pp. 1559–1562, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Kasperlik-Załuska, B. Czarnocka, and W. Jeske, “Addison's disease,” Journal of Clinical Endocrinology and Metabolism. In press.
  17. A. Söderbergh, F. Rorsman, M. Halonen, et al., “Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 1, pp. 460–463, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. A. G. Myhre, M. Halonen, P. Eskelin, et al., “Autoimmune polyendocrine syndrome type 1 (APS I) in Norway,” Clinical Endocrinology, vol. 54, no. 2, pp. 211–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Söderbergh, A. G. Myhre, O. Ekwall, et al., “Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 557–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Johannsson, R. Bergthorsdottir, A. G. Nilsson, H. Lennernas, T. Hedner, and S. Skrtic, “Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study,” European Journal of Endocrinology, vol. 161, no. 1, pp. 119–130, 2009. View at Publisher · View at Google Scholar · View at Scopus